MetLife director Diana McKenzie acquires 544 shares
The shares represent a portion of non-management director retainer fees and were deferred under the directors’ compensation plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MetLife, Inc. director Diana McKenzie acquired 544 shares of common stock on October 1, 2026, as a portion of non-management director retainer fees paid in common stock. The reported price was $94.35 per share, and her direct holdings after the transaction were 25,929 shares. McKenzie elected to defer receipt of the shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 544 | $94.35 | $51K |
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
Key Figures
Key Terms
non-management director retainer fees financial
defer receipt financial
MetLife Deferred Compensation Plan for Non-Management Directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the price of Diana McKenzie’s MET stock award?
AI-generated analysis. How Rhea-AI works. Not financial advice.